Goldmann, Ulrich https://orcid.org/0000-0003-1120-6912
Wiedmer, Tabea https://orcid.org/0000-0002-0355-9315
Garofoli, Andrea https://orcid.org/0000-0003-4651-5379
Sedlyarov, Vitaly https://orcid.org/0000-0002-9872-3535
Bichler, Manuel
Haladik, Ben https://orcid.org/0000-0001-6903-7379
Wolf, Gernot https://orcid.org/0000-0002-3943-8662
Christodoulaki, Eirini https://orcid.org/0000-0001-9834-1257
Ingles-Prieto, Alvaro https://orcid.org/0000-0002-5409-8571
Ferrada, Evandro https://orcid.org/0000-0003-3242-1726
Frommelt, Fabian https://orcid.org/0000-0003-3666-8005
Teoh, Shao Thing https://orcid.org/0000-0002-5938-258X
Leippe, Philipp https://orcid.org/0000-0002-1109-5610
Onea, Gabriel https://orcid.org/0000-0003-3782-4882
Pfeifer, Martin https://orcid.org/0000-0001-9126-5685
Kohlbrenner, Mariah https://orcid.org/0009-0005-3481-2466
Chang, Lena
Selzer, Paul https://orcid.org/0009-0005-9616-6017
Reinhardt, Jürgen https://orcid.org/0000-0002-8226-5429
Digles, Daniela https://orcid.org/0000-0001-5934-3559
Ecker, Gerhard F https://orcid.org/0000-0003-4209-6883
Osthushenrich, Tanja https://orcid.org/0009-0004-7536-5140
MacNamara, Aidan https://orcid.org/0000-0001-5958-2429
Malarstig, Anders https://orcid.org/0000-0003-2608-1358
Hepworth, David https://orcid.org/0009-0009-6787-4662
Superti-Furga, Giulio https://orcid.org/0000-0002-0570-1768
Funding for this research was provided by:
Innovative Medicines Initiative 2 (777372)
Innovative Medicines Initiative 2 (101034439)
Austrian Academy of Sciences
Austrian Science Fund (KLI1056)
Article History
Received: 17 October 2024
Revised: 28 March 2025
Accepted: 11 April 2025
First Online: 12 May 2025
Disclosure and competing interests statement
: GS-F is a co-founder and owns shares of Solgate GmbH, an SLC-focused company. DH and AM are employees and stockholders of Pfizer.